Forbes December 25, 2020
Sai Balasubramanian, J.D.

Verily announced late last week that it just completed a fresh investment round and has raised nearly $700 million in funding from prominent investors. The funding comes at a time when the healthcare and life-sciences industries are facing multiple stressors, especially in the context of Covid-19 and the transforming landscape of clinical medicine.

Verily is a cutting-edge organization with a broad vision. Its interests include spearheading life-sciences research, innovation in healthcare delivery, and harnessing technology and digital tools to improve health outcomes and patient care, just to name a few.

According to the press release, “The capital will be used to support rapid expansion of some of Verily’s leading commercial businesses. These include ​Baseline​, an end-to-end ecosystem designed to make...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Biotechnology, Digital Health, Healthcare System, Investments, Pharma / Biotech, Population Health Mgmt, Technology, Trends
How has U.S. Spending on Health Care Changed Over Time?
Merck enters $2B licensing deal for weight loss drug
How Medicare Negotiated Drug Prices Compare to Other Countries
The Fed's Warnings On Inflation Are Bad News For Biotech Startups
AI Tech Firm SandboxAQ Adds $300M to Ramp Up Development of LQMs for Drug Discovery & More

Share This Article